Keyphrases
Dutasteride
100%
Prostate Cancer Model
100%
VCaP
55%
Antiandrogen
44%
Prostate Cancer
33%
Tumor Burden
22%
Cell Proliferation
22%
Reductase
22%
Isoenzymes
22%
Cell Invasion
22%
TMPRSS2-ERG Fusion
22%
Cell-to-cell
11%
Gene Expression
11%
Therapeutic Efficacy
11%
Expression Level
11%
Therapeutic Intervention
11%
Androgens
11%
Cell Growth
11%
5′-untranslated Region (5′-UTR)
11%
Overexpression
11%
Tumor Progression
11%
Testosterone
11%
ETS Transcription Factors
11%
Family Members
11%
Prostate Cancer Cell Lines
11%
Gene Fusion
11%
Androgenic
11%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
11%
Localized Prostate Cancer
11%
Cancer Cases
11%
Xenograft Model
11%
Fusion Gene
11%
5α-reductase Inhibitors
11%
ETS-related Gene
11%
Transmembrane Protease Serine 2 (TMPRSS2)
11%
ERG Fusion
11%
Xenograft Tumor Model
11%
Gene Drive
11%
SRD5A1
11%
Androgen-regulated Genes
11%
Bicalutamide
11%
SRD5A3
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cancer Model
100%
Dutasteride
100%
Antiandrogen
44%
Neoplasm
22%
Isoenzyme
22%
Oxidoreductase
22%
Androgen
22%
Combination Therapy
11%
Tumor Growth
11%
Transcription Factor
11%
Tumor Model
11%
Steroid 5alpha Reductase
11%
Bicalutamide
11%